Statins and Micronutrients: Unanswered Questions

Shepherd J. , Cobbe S.M. , Ford I. . Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301–7

Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7–22

Sacks F.M. , Pfeffer M.A. , Moye L.A. . The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial Investigations. N Engl J Med 1996; 335: 1001–9

Laufs U. , La Fata V. , Pkutzky J. , Liao J.K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129–35

Laufs U. , Liao J.K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by rho GTPase. J Biol Chem 1998; 273: 24266–71

Matsuno H. , Takei M. , Hayashi H. , Nakajima K. , Ishisaki A. , Kozawa O. Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries. J Cardiovasc Pharmacol 2004; 43: 333–40

Moat S.J. , Lang D. , McDowell I.F. . Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem 2004; 15: 64–79

Boushey C.B. , SA Omenn G.S. , Moultsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049–57

Moat S.J. , Doshi S.N. , Lang D. , McDowell I.F. , Lewis M.J. , Goodfellow J. Treatment of coronary heart disease with folic acid: is there a future? Am J Physiol Heart Circ Physiol 2004; 287: H1–7

Li A.C. , Brown K.K. , Silvestre M.J. , Willson T.M. , Palinski W. , Glass C.K. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2000; 106: 523–31

Collins R. , Armitage J. , Parish J. , Sleight P. , Peto R. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005–16

Van Etten R.W. , de Koning E.J. , Honing M.L. , Stroes E.S. , Gaillard C.A. , Rabelink T.J. Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 2002; 22: 799–804

Van de Ree M.A. , Huisman M.V. , de Man F.H. , van der Vijver J.C. , Meinders A.E. , Blauw G.J. Impaired endothelium-independent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin. Cardiovasc Res 2001; 52: 299–305

Van Etten R.W. , de Koning E.J. , Verhaar M.C. , Gaillard C.A. , Rabelink T.J. Impaired NO-dependent vasodilation in patients with type II (non-insulin dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 2002; 45: 1004–10

Tan K.C. , Chow W.S. , Tam S.C. , Ai V.H. , Lam C.H. , Lam K.S. Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilatation in type 2 diabetes mellitus. J Clin Endocrinol Metab 2002; 87: 563–8

Timimi F.K. , Ting H.H. , Haley E.A. , Roddy M.A. , Ganz P. , Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with insulin dependent diabetes mellitus. J Am Coll Cardiol 1998; 31: 552–7

Heller R. , Unbehaun A. , Schellenberg B. , Mayer B. , Werner-Felmayer G. , Werner E.R. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 2001; 276: 40–7

de Lorgeril M. , Salen P. , Martin J.L. , Monjaud I. , Delaye J. , Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779–85

Liem A.H. , van Boven A.J. , Veeger N.J. , Withagen A.J. . Folic Acid on Risk Diminishment After Acute Myocardial Infarction Study Group. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. Int J Cardiol 2004; 93: 175–9